While both multislice CT and endoscopic ultrasound can evaluate the local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam, providing superior staging of T3 and T4 cancers, according to a study from Austria presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.
While both multislice CT and endoscopic ultrasound can evaluate the local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam, providing superior staging of T3 and T4 cancers, according to a study from Austria presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.
Dr. Ahmed Ba-Ssalamah, a radiologist at the Medical University of Vienna, and colleagues enrolled 23 patients with esophageal carcinoma. Patients underwent endoscopic sonography and contrast-enhanced MSCT scanning using a gas-water GI-filling technique.
Endoscopic ultrasound and MSCT each provided a 100% sensitivity rate for tumor detection, but the sensitivity of other endpoints varied. Ultrasound was favored for tumor staging (89% versus 79%) and for diagnosis of local node involvement (82% versus 76%). CT came out on top in diagnosing distant node involvement and other metastases (65% versus 92%).
The researchers performed ultrasound scanning using a fiber-optic endoscope with a 5-1-MHz electronic array that provides a 360° scanning angle. They performed CT with a 16-slice scanner and a bowel distention protocol including gas granules and water for the esophagus and stomach, respectively, and a contrast injection using a bolus-tracking technique.
Their acquisition protocol included slice thicknesses of 0.5 mm and 1.5 mm, respectively, for the thoracocervical and abdominal regions. They used postsurgical histopathologic results as their comparative gold standard.
MSCT offers a field-of-view depth superior to endoscopic ultrasound for staging and detection of local disease and distant lymph node metastases, Ba-Ssalamah said. But MSCT isn't perfect Differentiation between T1 and T2 stages using the bowel distention-plus contrast technique is difficult, if not impossible. And MSCT's spatial resolution is still inferior to endoscopic ultrasound.
Clinical experience in the preoperative staging of esophageal cancer indicates that the two techniques are complementary rather than competitive in this realm, he said.
For more information from the Diagnostic Imaging archives:
Virtual endoscopy detects, characterizes gastric cancer
Anatomic, functional imaging collaborate in cancer detection
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.